Höppner, J.; Casteleyn, V.; Biesen, R.; Rose, T.; Windisch, W.; Burmester, G.R.; Siegert, E.
SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis. Pharmaceuticals 2022, 15, 1198.
https://doi.org/10.3390/ph15101198
AMA Style
Höppner J, Casteleyn V, Biesen R, Rose T, Windisch W, Burmester GR, Siegert E.
SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis. Pharmaceuticals. 2022; 15(10):1198.
https://doi.org/10.3390/ph15101198
Chicago/Turabian Style
Höppner, Jakob, Vincent Casteleyn, Robert Biesen, Thomas Rose, Wolfram Windisch, Gerd Rüdiger Burmester, and Elise Siegert.
2022. "SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis" Pharmaceuticals 15, no. 10: 1198.
https://doi.org/10.3390/ph15101198
APA Style
Höppner, J., Casteleyn, V., Biesen, R., Rose, T., Windisch, W., Burmester, G. R., & Siegert, E.
(2022). SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis. Pharmaceuticals, 15(10), 1198.
https://doi.org/10.3390/ph15101198